Drugs that contain Ombitasvir; Paritaprevir; Ritonavir
1. List of Technivie drug patents
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents protects the active chemical substance. Only patent owner can launch products that use this active substance. | ||||
| US8642538 | ABBVIE INC | Macrocyclic hepatitis C serine protease inhibitors |
Sep, 2029
(6 years from now) | |
| US8420596 | ABBVIE INC | Macrocyclic hepatitis C serine protease inhibitors |
Apr, 2031
(8 years from now) | |
| US8691938 | ABBVIE INC | Anti-viral compounds |
Apr, 2032
(9 years from now) | |
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8399015 | ABBVIE INC | Solid pharmaceutical dosage form |
Aug, 2024
(1 year, 5 months from now) | |
| US8268349 | ABBVIE INC | Solid pharmaceutical dosage form |
Aug, 2024
(1 year, 5 months from now) | |
|
US8399015
(Pediatric) | ABBVIE INC | Solid pharmaceutical dosage form |
Feb, 2025
(1 year, 11 months from now) | |
|
US8268349
(Pediatric) | ABBVIE INC | Solid pharmaceutical dosage form |
Feb, 2025
(1 year, 11 months from now) | |
| US9006387 | ABBVIE INC | Anti-viral compounds |
Jun, 2030
(7 years from now) | |
| US9044480 | ABBVIE INC | Compositions and methods for treating HCV |
Apr, 2031
(8 years from now) | |
| US8686026 | ABBVIE INC | Solid compositions |
Jun, 2031
(8 years from now) | |
|
US8420596
(Pediatric) | ABBVIE INC | Macrocyclic hepatitis C serine protease inhibitors |
Oct, 2031
(8 years from now) | |
Market Authorisation Date: 24 July, 2015
Treatment: Treatment of hcv infection using ombitasvir; Treatment of hcv infection using paritaprevir
Dosage: TABLET;ORAL
TECHNIVIE family patents
62
United States
24
European Union
20
Japan
15
Spain
15
China
13
Croatia
13
Slovenia
13
Poland
13
Denmark
12
Portugal
12
Taiwan, Province of China
12
Korea, Republic of
11
Canada
11
Cyprus
10
Uruguay
10
New Zealand
10
Argentina
10
Mexico
10
Peru
10
Hong Kong
10
South Africa
10
Hungary
10
Chile
9
EA
9
Israel
8
Guatemala
8
Brazil
8
Ukraine
8
Ecuador
8
RS
7
Dominican Republic
7
Lithuania
5
Singapore
5
Costa Rica
5
Norway
5
Australia
4
Turkey
4
Malaysia
4
Colombia
3
Luxembourg
3
Netherlands
2
ME
1
El Salvador
1
Panama
1
San Marino
1
Philippines
1
Georgia
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic